Secondaries announced 10.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: AxoGen, Inc.
Symbol: AXGN
Price: Last trade $8.24
Description: No re-offer range available
Trade Date: 10/7
Shares: 1.8 million
Underwriter(s)JMP Securities
Co Manager(s)Dougherty & Co.
Rating=Subscription Needed

Company: Cidara Therapeutics, Inc.
Symbol: CDTX
Price: Last trade $11.29
Description: No re-offer range available
Trade Date: 10/7
Shares: 2 million
Underwriter(s)Cantor Fitzgerald
Rating=Subscription Needed